title: Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice.
abstract: We show here that BALB/c mice inoculated with murine cytomegalovirus (MCMV) express viral antigens in the endothelial and smooth muscle cells of the aortic wall, and that accumulation of inflammatory cells in the aortic lumen, similar to that seen in early atherosclerotic lesions in humans, colocalizes with the site of virus antigen expression. Immunosuppression of the mice at the time of virus infection increased the expression of viral antigens and the size of early atherosclerotic lesions in the intima. The percentage of the low-density lipoprotein cholesterol (LDL-C), the major lipid contributor to atherosclerotic plaques, was significantly increased in the serum of MCMV-infected mice, whether or not the mice were fed a high cholesterol diet. Human cytomegalovirus (HCMV) significantly increased the esterified cholesterol component of the total cholesterol in a human arterial smooth muscle cell line infected in vitro with HCMV. These results suggest that CMV infection is involved in two of the major mechanisms that lead to development of atherosclerosis, i.e., immune injury and high LDL-C.
authors.affiliation: Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104, USA.
authors.forename: K
authors.initials: K
authors.lastname: Berencsi
authors.forename: V
authors.initials: V
authors.lastname: Endresz
authors.forename: D
authors.initials: D
authors.lastname: Klurfeld
authors.forename: L
authors.initials: L
authors.lastname: Kari
authors.forename: D
authors.initials: D
authors.lastname: Kritchevsky
authors.forename: E
authors.initials: E
authors.lastname: Gönczöl
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000096:biosynthesis; D001018:Aortic Diseases / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D001025:Aortitis / Q000209:etiology / Q000821:virology; D001161:Arteriosclerosis / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D002791:Cholesterol, Dietary / Q000493:pharmacokinetics; D008078:Cholesterol, LDL / Q000097:blood; D003433:Crosses, Genetic; D003586:Cytomegalovirus Infections / Q000097:blood / Q000150:complications* / Q000276:immunology; D004036:Diet, Atherogenic; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology / Q000821:virology; D005260:Female; D006937:Hypercholesterolemia / Q000209:etiology*; D007165:Immunosuppression Therapy; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018146:Muromegalovirus / Q000276:immunology / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000473:pathology / Q000821:virology; D017539:Tunica Intima / Q000473:pathology; D014779:Virus Replication; D014916:Whole-Body Irradiation
chemical_list: D000956:Antigens, Viral; D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL